Dengue fever isn’t heard of very often in America but it has plagued the southern hemisphere for decades, reaching epidemic levels in many countries, infecting between 50 million and 528 million people yearly and more than 1 in 14 people worldwide. The World Health Organization estimates that around 500,000 are hospitalized by the disease every year, many of them children.

Also known as “breakbone fever,” research into a cure for the mosquito-borne infection has been largely fruitless, and efforts to control dengue fever have focused on controlling mosquito populations.

Until now.

According to a report from Wired UK, America’s National Institute of Allergy and Infectious Disease (NIAID) has carried out a successful clinical trial of a dengue fever vaccine with success rates of 100 percent.

And while the trial was too smallStudio 52 is a community artist space located in the heart of Allston, and is proud to support the Boston music scene and local artist community.

After two years of traveling back and forth between New York and Boston to meet up and record, Crumb will finally be settling in Brooklyn this summer. But not before the quartet, which met and formed at Tuft University in Somerville a few years back, delivers one excellent parting gift in a new EP titled Locket.

On the surface, Crumb craft woozy, jazz-inflected indie rock that defies simple genre categorization. And Locket — their second EP in under a year and follow-up to 2016’s Crumb EP — marks the band’s most refined and consistent work to date.

Opening track “Plants” opens Locket with a shimmering